← Back to Search

Diagnostic Device

Investigational Ultrasound Imaging for Liver Fat Quantification for Non-alcoholic Fatty Liver Disease

N/A
Waitlist Available
Led By Smita S Bailey, MD
Research Sponsored by Philips Clinical & Medical Affairs Global
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intra-procedural (1 day)
Awards & highlights

Study Summary

This study is evaluating whether a new ultrasound technique can help detect liver fat.

Eligible Conditions
  • Non-alcoholic Fatty Liver Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intra-procedural (1 day)
This trial's timeline: 3 weeks for screening, Varies for treatment, and intra-procedural (1 day) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Correlation of the liver fat percentage reported from MRI-PDFF with measurements of ultrasound biomarkers for liver fat.
Secondary outcome measures
Inter-operator variability in measurements of ultrasound biomarkers for liver fat
Ultrasound biomarker measurement failure rate

Trial Design

1Treatment groups
Experimental Treatment
Group I: Investigational Ultrasound Imaging for Liver Fat QuantificationExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Investigational Liver Fat Quantification Software
2020
N/A
~100

Find a Location

Who is running the clinical trial?

Philips Clinical & Medical Affairs GlobalLead Sponsor
50 Previous Clinical Trials
16,544 Total Patients Enrolled
1 Trials studying Non-alcoholic Fatty Liver Disease
63 Patients Enrolled for Non-alcoholic Fatty Liver Disease
Smita S Bailey, MDPrincipal InvestigatorPhoenix Children's Hospital
~8 spots leftby Jun 2025